Skip to main content

Table 1 The relationship between CD90 expression and clinical parameters in human HCC (n = 66)

From: miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma

Parameters

CD90Low

CD90High

p Value

Male/Female

 

34/4

26/2

0.969

Age*

 

52 (32-75)

45.5 (32-60)

0.524

HBsAg

    
 

Positive

34 (89.5 %)

25 (89.3 %)

1.000

 

Negative

4 (10.5 %)

3 (10.7 %)

AFP

    
 

Normal

14 (36.8 %)

12 (42.9 %)

0.629

 

High

24 (63.2 %)

16 (57.1 %)

Vascular Invasion

    
 

Positive

2 (5.3 %)

9 (32.1 %)

0.010

 

Negative

36 (94.7 %)

19 (67.9 %)

Tumer Size(cm)*

 

4.75 (2-18)

6.5 (3-16)

0.077

Recurrence

 

21 (55.3 %)

24 (85.7 %)

0.009

Edmondson Grade

I/II

25 (65.8 %)

15 (53.6 %)

0.315

 

III/IV

13 (34.2 %)

13 (46.4 %)

  1. *Value expressed in the midian with the range in parentheses